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Objectives: Determine if arm veins are good conduits for infrainguinal revascularisation and should be
used when good quality saphenous vein is not available.
Design: Retrospective study.
Materials and methods: We evaluated a consecutive series of infrainguinal bypass (IB) using arm vein
conduits fromMarch 2001 to December 2006.We selected arm vein by preoperative ultrasound mapping
to identify suitable veins. We measured vein diameter and assessed vein wall quality. We followed
patients with systematic duplex imaging at 1 week, 1, 3, 6 and 12 months, and annually thereafter. We
treated signiﬁcative stenoses found during the follow-up.
Results: We performed 56 infrainguinal revascularisation using arm vein conduits in 56 patients. Primary
patency rates at 1, 2 and 3 years were 65%, 51% and 47%. Primary assisted patencies at 1, 2 and 3 years
were 96%, 96% and 82%. Secondary patency rates at 1, 2 and 3 years were 92%, 88% and 88%. The three-
year limb salvage rate was 88%.
Conclusions: We conclude that infrainguinal bypass using arm vein for conduits gives good patency rates,
if selected by a preoperative US mapping to use the best autogenous conduit available.
 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.With the improvement in the quality of life and medical ther-
apies, there is an increase in both life expectancy and the patient’s
expectations. Medicine has to cope with older patients and their
growing lists of comorbidities,1 thereby complicating the frame-
work conditions for vascular surgery.
In fact, the ageing patient is apt to beneﬁt from a bypass (be it
cardiac or leg), and surgical options are now considered even for
elderly patients. Nevertheless, the fundamental problem of
a limited number of great saphenous veins (GSVs) available per
patient still remains.
Bioengineering has already tried to solve this lack of conduit, but
without success.2 Veins are still considered superior to prostheses
in terms of long-term patency,3e14 and the GSV remains the conduit
of choice.6e12 However, other surgeons or pathologies may have
laid claim ﬁrst to this valued vein.tions on this paper, please go
lair).
ciety for Vascular Surgery. PublisheBased on numerous studies,3,6,15 vascular surgery teams still
advocate an all-autogenous policy for infrainguinal bypass (IB).
What remains unclear is which vein should be used.
We decided to work in the ‘do the best operation ﬁrst’ fashion
and this series reﬂects consecutive IB where the arm vein was the
best alternative conduit for lower extremity revascularisations
based on systematic preoperative duplex mapping.
The aim of this study was to evaluate the arm veins as conduits
for IB and to look for factors that could inﬂuence the survival and
the patency rates.Materials and Methods
Between March 2001 and December 2006, all patients under-
going infrainguinal arterial revascularisation at the Lausanne
University Hospital (Centre Hospitalier Universitaire Vaudois-
CHUV) were recorded prospectively in a computerised database.
Retrospectively, we selected a consecutive series of IB where the
arm vein served as graft. Operative reports were then coordinated
with patients’ demographics, comorbidities, presenting symptoms
and angiographic reports. Staging of arteriopathy was done usingd by Elsevier Ltd. All rights reserved.
F. Vauclair et al. / European Journal of Vascular and Endovascular Surgery 43 (2012) 48e53 49Rutherford categories. Patients were stratiﬁed using ASA anaes-
thesiologic scoring.16,17
During this 5-year period, 62 lower extremity revascularisa-
tions using arm vein conduits were performed in 56 patients
(six patients were operated on both legs). This represents
approximately 7% of all IBs done during this period at our
department. To simplify demographic and statistical analysis, we
choose to exclude the second operation performed on six
patients.
All patients underwent preoperative clinical examination,
angiography or angio-CT, as well as both arterial and venous
ultrasound (US) scanning. When lower limbs did not provide
enough venous material to perform the planned bypass, upper
limbs were likewise examined. After inspection and palpation
with and without application of a tourniquet, deep veins were
scanned using B-mode sonography to rule out a deep vein
thrombosis. Then the superﬁcial veins, the great and short
saphenous veins or the cephalic and basilic veins, as well as
their main branches, were located and scanned throughout their
courses, also using B-mode. Diameters were assessed at several
levels, and alterations, such as thrombosis, aneurysm, focal wall
thickening or calciﬁcations and intraluminal webs were sought.
‘Any patent venous segment showing a straight course, an even
and thin wall and a minimal luminal diameter of 2.5 mm was
regarded as suitable for use as a conduit’ (we deﬁned vein of
poor quality when one or more criteria were observed, such as
diameter <2.5 mm, thrombosis, aneurysm, focal wall thickening
or calciﬁcations and intraluminal webs). When the diameter was
less than 2.5 mm, measurements were repeated after heating
the limb and asking the patient to perform movements with his
foot or hand while wearing a cuff inﬂated to 80 mmHgFigure 1. Pre-operative duplex mapping.proximally on the limb. All ultrasound studies were performed
using linear 5e12 MHz transducers (Envisor and HDI 5000,
Philips Medical Systems Switzerland, Gland, Switzerland;
Vingmed System V, GE Medical Systems Switzerland, Glattbrugg,
Switzerland).
Then, based on preoperative US mapping ﬁndings (Fig. 1),
selected veins were isolated and harvested after ligation of the
collaterals (Fig. 2). When a single segment of suitable length was
not present, we performed spliced vein bypasses (composite) using
venous-to-venous and end-to-end anastomosis done with single
stitches (polypropylene 7.0).
Before arterial ﬂow interruption and arteriotomy, we used
a single dose (50 UI/Kg) of intravenous heparin.
At the end of the procedure, the ﬂow was measured using
a transit time principle probe (Medistim, Oslo, Norway) placed
around the venous conduit just distal to the proximal anastomosis.
When blood ﬂow was under 25 ml/min, an intraoperative digital
subtraction angiography (DSA) was performed in order to detect
and correct any stenosis or other bypass problem. If nothing was
found, we assumed that low ﬂow was due to poor run-off.
In order to reduce operative time, the operation was performed
using a two-team approach.
For below-the-knee bypasses, anticoagulation therapy with
intravenous heparin was started 6 h post-op and then the patient
was later switched to an oral anticoagulant on day seven (to
minimise haemorrhagic complications and to delay oralFigure 2. Preparation of arm vein with ligation of collaterals.
Table 1
Patients’ characteristics at the time of bypass and staging of Arteriopathy.24
Category 0: asymptomatic; 1: mild claudication; 2: moderate claudication; 3:
severe claudication; 4: ischaemic rest pain; 5: minor tissue loss-nonhealing
ulcer, focal gangrene with diffuse pedal ischaemia; 6: major tissue loss-
extending above transmetatarsal level, functional foot no longer salvageable.
Results are expressed as number of subjects and (percentage).
N ¼ 56
Male sex 28 (50.0)
Age (years) 75.7  10.6
Hypertension 47 (83.9)
Hypercholesterolaemia 21 (37.5)
Diabetes mellitus 21 (37.5)
Current smoker 30 (53.6)
Renal insufﬁciency 31 (55.4)
Glomerular ﬁltration rate (ml/min) 37.1  12.7
Coronary disease 37 (66.1)
Rutherford’s category
3 6 (10.7)
4 12 (21.4)
5 23 (41.1)
6 15 (26.8)
Table 2
Bypass characteristics. Results are expressed as number of bypass procedures and
(percentage) or as mean  standard deviation. *Distal anastomosis is beneath the
trifurcation (corresponding to anterior/posterior tibial or peroneal artery or pedal
arch).
N ¼ 56
Vein diameter (mm) 4.1  1.1
4 [3e5]; (2e8)
Venous conduit characteristics
Single vessel (cephalic, basilic or brachial) 30 (53.6)
Spliced armeleg (saphenous and arm veins) 18 (32.1)
Spliced armearm (basilic and cephalic) 8 (14.3)
Type of revascularization
Above-knee bypass 17 (30.4)
Below-knee bypass 11 (19.6)
Distal bypass* 28 (50.0)
Elective surgery 46 (82.1)
Redo surgery 27 (48.2)
Take-off vessel
Common femoral artery (CFA) 11 (19.6)
Superﬁcial femoral artery 18 (32.1)
Profound femoral artery (PFA) 14 (25.0)
Suprageniculate popliteal artery (SPA) 6 (10.7)
Infrageniculate popliteal artery 4 (7.1)
AorticePFA bypass 1 (1.8)
SFAeATA bypass (proximal part) 1 (1.8)
CFAeSPA bypass 1 (1.8)
Landing vessels
Suprageniculate popliteal artery 11 (19.6)
Geniculate popliteal artery (GPA) 5 (8.9)
Infrageniculate popliteal artery 12 (21.4)
Peroneal artery (PA) 11 (19.6)
Anterior tibial artery 8 (14.6)
Posterior tibial artery 3 (5.4)
Dorsalis pedis artery (DPA) 4 (7.1)
SFAePA bypass 1 (1.8)
GPAeDPA bypass 1 (1.8)
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duplex imaging).
After surgery, patients underwent periodic systematic evalu-
ations at 1 week, 1, 3, 6 and 12 months, and annually thereafter.
These included history and lower limb inspection looking for
progression of ischaemic symptoms. We performed ankle and toe
pressure measurements, and duplex imaging of the entire length
of the bypass, as well as of the feeding artery and the main
outﬂow vessel. Variations in the diameter, thrombus and location
of the anastomoses were assessed by B-mode and stenoses were
sought using colour Doppler. Spectral Doppler with an angle of
60 was used to assess velocity waves and peak systolic velocities
(PSVs) proximal to, at and distal to sites of stenosis. Velocity
ratios were recorded across all lesions and were calculated by
dividing the maximal PSV at the stenosis site by the PSV proximal
to the stenosis. The severity of a stenosis was considered to be
about 50% when the PSV ratio was 2.2e2.5, and at least 70% when
the systolic wave was dampened distal to the stenosis and the
PSV ratio was 3.5 or more. Then all stenoses were carefully
scanned using B-mode to assess their minimal luminal diameter,
length and cause (valve, thrombus, conduit stricture, dissection or
plaque). Stenoses of 50% were monitored closely, whereas
stenoses of 70% or more were treated using either common
percutaneous balloon angioplasty or surgically with a venous
patch.20e23
Deﬁnitions
All terms used to report patencies and bypass characteristics are
based on Rutherford’s24 recommendations.
Statistical analysis
Statistical analysis was performed using SAS v.9.2 (SAS Inc, Cary,
NC, USA). Results were expressed as the number of subjects and
(percentage) or as the mean standard deviation, unless otherwise
stated. Patency rates were assessed by the life table method using
2-month intervals and the results were expressed as 1, 2 or 3-year
patency rates and [95% conﬁdence interval]. Factors signiﬁcantly
related to patency rates were assessed using the log-Rank test.
Statistical signiﬁcance was set at p < 0.05.
Results
Data from 56 patients aged 75.7  10.5 years ((mean  SD)
range: 48e93 years) were collected. The male/female ratio was 1/1
(28 M/28 F). The main clinical characteristics of the patients at
baseline are summarised in Table 1. Staging of arteriopathy shows
that two-thirds of the procedures were performed for Rutherford
categories 5 or 6 (Table 1).
The GSV was missing in 53.6% (30/56), present but too short or
of poor quality in 46.4% (26/56). Table 2 shows the principal bypass
characteristics. Here, it is important to mention that the rate of redo
operations reached 48% and that infrapopliteal bypasses, at 50%,
were the most commonly performed.
Six patients have been operated on both legs. Data from the
second contralateral intervention were excluded from the analysis
and are reported separately.
Survival and complication rates
There was no in-hospital death. Local complications were
observed in four patients (7.1%), corresponding to three haemato-
mas in the arm (requiring evacuation) and one transient paraes-
thesia of the fourth and ﬁfth digits after cephalic harvesting.Survival rates were 85%, 72% and 50% at 12, 24 and 36 months,
respectively.
Patency and limb salvage
Primary patency rates at 1, 2 and 3 years were 65  6.7%,
51 7.3% and 47  7.6%. Primary assisted patency rates at 1, 2 and 3
years were 96  3.0%, 96  3.0% and 82  6.9%. Secondary patency
rates at 1, 2 and 3 years were 92  3.7%, 88  4.7% and 88  4.7%
(Fig. 3).
Figure 3. Kaplan-Meier survival curves.
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time of 41 [range 17e167] days, corresponding to six minor and six
major amputations. At the end of the follow-up, the limb salvage
rate was 88.0% (44 from the 50 patients with critical limb
ischaemia).
Factors related to survival and patency
We used the Log Rank test to assess the variables signiﬁcantly
related to patency rates.
Neither clinical nor surgical variables were associated with
primary patency rates.
Vein diameter was inversely related to primary assisted rates. An
increase of 1 mm reduced the risk of occlusion by about 50%
(HR ¼ 0.54, 95% conﬁdence interval [0.30e0.98], p ¼ 0.04).
For secondary patency rates, a signiﬁcant association was found
with spliced vein graft (p < 0.01) but it was not possible to assess
HR as one group (single vessel) had a 3-year patency rate of 100%,
whereas the groupwhich received a spliced graft had a patency rate
of 73.1  9.6% (see supplemental Fig. 1).
By contrast, the location of a landing vessel (above/below knee/
distal) did not statistically inﬂuence the outcome.
Concerning the stage of ischaemia, the patency rates of Ruth-
erford stage 3 versus 4e6 were not statistically different. This lack
of difference is probably due to the small number of patients with
stage 3.
Discussion
The results of our study suggest that arm veins contribute to
satisfying results in terms of patency rates and limb salvage. Indeed,
we performed IB with arm veins in 56 patients who were treated
mostly for critical limb ischaemia with a limb salvage of 88% at 3
years.
Many studies have highlighted the superiority of venous
conduits compared to synthetic ones for infrainguinal revascular-
isation.3,7,14 Peirera et al. published in 2006 a meta-analysis of
femoropopliteal bypass grafts for lower extremity insufﬁciency and
concluded that GSV performs better than PTFE in femoropopliteal
bypass grafting and should be used whenever possible.25Mahmood et al. reported that even composite (vein-prosthetic)
sequential grafts are not as good as the autologous vein. Interest-
ingly, they found no difference in patency between composite
grafts constructed from the arm or leg vein.26 Several retrospective
studies have shown that even alternative veins (other than GSV)
have satisfactory patency rates.3,4,10,11,15,18 Previously, the arm vein
was usually used to perform very distal bypass in patients without
GSV or as an alternative to preserve the contralateral GSV. In these
cases, some studies have achieved secondary patency and limb
salvage rates equal to those of GSV.3,4,11,15,18
We decided to use arm veins each time as they were the best
conduits available even if the GSVwas present. This idea is based on
the fact that the long-term survival of grafts depends ﬁrst and
foremost on the quality of the conduit.6e9 During the same study
period and with the same policy, Arvela et al. have compared 130
arm vein grafts with 160 prosthetic ones. Their results conﬁrmed
the superiority of arm veins over prosthetic conduits, even when
spliced (patency is not statistically affected by the number of vein
segments).27
Vein quality was assessed preoperatively by duplex mapping.
We deﬁned a vein to be of poor quality when one or more criteria
were observed, such as diameter <2.5 mm, thrombosis, aneurysm,
focal or diffuse wall thickening or calciﬁcations and intraluminal
webs. We selected arm vein when the diameter was sufﬁcient, the
quality was excellent and the length adequate for harvesting. US
mapping is crucial due to the numerous vein punctures in hospi-
talised patients, which is harmful for patency.
As in other studies, it is important to note that arm vein bypass
results are not really comparable with GSV bypass because
patients’ basic vascular status is worse (high rate of redo
operations).
Nevertheless, our results of patency and limb salvage at 3
years were quite satisfying and even similar to those using GSV,
being comparable to those found in the literature.4,5,18,19 The
endovascular treatment of critical limb ischaemia is increasing all
around the world. The Basil trial comparing endovascular and
open surgery concluded that patients with life expectancy >2
years and good quality of GSV should be treated by open
surgery.28 Our study supports the fact that vein arms should be
explored by US and used when available because they contribute
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the presence of good vein arms should be evoked when an
endovascular treatment for long arterial occlusion is considered.
In this analysis, vein diameter was shown to be an important
protective factor of assisted patency rates, whereas it exerted no
statistically signiﬁcant effect on secondary patency rates.
Vein diameter is probably not the only factor inﬂuencing the
occlusion rate which could be more affected by conduit, inﬂow
and outﬂow qualities. In contrast to vein diameter, spliced vein
grafts signiﬁcantly decreased the secondary patency rates. This is
probably related to the number of anastomoses. To minimise the
stenosing effect of anastomosis, we made separate simple stitch
sutures. We performed systematic duplex scanning of the
bypasses to treat signiﬁcative stenosis before occlusion. The strict
follow-up of patients should be accurate during the ﬁrst 6
months because 50% of the occlusion occurs during the ﬁrst half-
year.5
During the study period, the management of signiﬁcative
stenosis was surgical in a majority of cases (85%) because we
previously had experiment arm vein rupture during balloon
angioplasty. Actually, we carefully performe balloon angioplasty
ourselves in the operating room and this is the procedure we prefer
for treatment of stenosis.
Regarding the relatively low survival rate, it should be noted
that the average age of our patients was older than in most cited
publications (where the average ages tend to be <70 y), and that
their general health status was relatively bad (mean ASA score of
3.02). According to Swiss statistical reports, more than 30% of
patients had reached their life expectancy (mean male/female life
expectancy in 2004 was 78.6/83.7 years) at the time of surgery.29
Our study has some limitations. Even if all IBs are recorded
prospectively in our department, the retrospective analysis has
some disadvantage linked to the design of the study. Moreover, the
small number of patients did not permit us to generalise the results
to every patient waiting for an IB.
In summary, we conclude that arm veins have good primary and
secondary patency rates even after 3 years with very few harvest-
ing complications.18,30 Arm veins selection by preoperative US
mapping using deﬁned criteria is essential to get the optimal
conduit even if spliced graft is necessary at the end. Its performance
should be evaluated by per-op ﬂow measurement using a sterile
ultrasound surgical probe, thereby allowing time to react in case
of inadequate values. Thereafter, a systematic duplex surveillance
programme is recommended to detect and treat the possible
stenosis.3,4,15,18 When these procedures are followed, there is hope
for limb salvage in the majority of cases.
Therefore, arm veins quality should always be evaluated when
good quality GSV is absent. Spliced vein grafts are effectivewhen no
long segment is available.Acknowledgements
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